ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Osteonecrosis of the jaw Osteonecrosis of the jaw (ONJ) has been reported uncommonly in clinical trials in patients receiving Zometa. Post-marketing experience and the literature suggest a greater frequency of reports of ONJ based on tumour type (advanced breast cancer, multiple m yeloma). A study showed that ONJ was
Tags:
Product, Summary, Characteristics, Summary of product characteristics, Osteonecrosis
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
Medication-Related Osteonecrosis of the Jaw—2014 Update
www.aaoms.orgPAGE 2 Medication-Related Osteonecrosis of the Jaw – 2014 Update ecules disrupting the angiogenesis-signaling cascade. These novel medications have demonstrated efficacy in the treatment of gastrointestinal tumors, renal cell carcinomas, neuroendocrine tumors and others. Risks of jaw necrosis related to antiresorptive therapy
Medication, Related, Osteonecrosis, Medication related osteonecrosis
Oral Health Management of Patients at Risk of Medication ...
www.sdcep.org.ukOral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw has been developed to help dental practitioners to manage the routine dental treatment of patients prescribed drugs associated with medication-related osteonecrosis of the jaw (MRONJ). This is an update to the previous SDCEP Oral Health Management of Patients
Risks, Medication, Related, Risk of medication related osteonecrosis of the, Osteonecrosis, Medication related osteonecrosis of the
American Association of Oral and Maxillofacial Surgeons ...
www.aae.orgSurgeons (AAOMS) Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws (Position Paper) and approved by the Board of Trustees in September 2006 1. The Position Paper was developed by a Task Force appointed by the Board and composed of clinicians with extensive experience in caring for these patients and basic science researchers.
Oral Health Management of Patients at Risk of Medication ...
www.sdcep.org.ukMedication-related Osteonecrosis of the Jaw Guidance in Brief For further details, please refer to the full guidance, available at www.sdcep.org.uk N.B. In the situation where a patient initially presents with an established history of anti-resorptive or anti-angiogenic drug use, follow the advice for extractions or other
Medication, Related, Osteonecrosis, Medication related osteonecrosis of the
DRUG NAME: Denosumab
www.bccancer.bc.carelated hypocalcemia may be prevented by supplementing with at least 500 mg calcium daily and 400 IU vitamin D daily. 2. Monitor for hypocalcemia and correct as necessary. 17. ... Dental Care: Osteonecrosis of the Jaw. INTERACTIONS: No information found. SUPPLY AND STORAGE:
ORAL AND DENTAL CONDITIONS INCLUDING MOUTH, LIPS …
www.benefits.va.govDec 02, 2020 · this is intended for loss of teeth due to service-related trauma. malunion or nonunion of maxilla if additional diagnoses that pertain to oral or dental conditions, list using above format: ... osteomyelitis, osteoradionecrosis or osteonecrosis of the jaw anatomical loss or injury of the mouth, lips or tongue.
Diagnostic Approach to Hip Pain - University of Michigan
medicine.umich.eduOsteonecrosis IT band syndrome Ischial apophysis avulsion Meralgia paresthetica Femoroacetabular impingement (FAI) Hamstring muscle strain/avulsion Athletic pubalgia (sports hernia) Loose bodies/chondral lesions Legg-Calve-Perthes disease Slipped capital femoral epiphysis Transient synovitis Septic arthritis Hip pointer